CBSET’s Michael Naimark will be addressing the clinicians and researchers at St. Jude Children’s Research Hospital on the topic: “Partnering for FDA Review: Approaches for Preclinical Outsourcing and CRO Evaluation.”
If you would like more information about this topic or about CBSET, please contact Michael.
Related CBSET brochures:
by Michael Naimark, MS, Director of Business Development at CBSET, Inc.
World Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, MS, Director of Business Development at CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, Founder and Chief Development Officer at CILcare